RE:RE:RE:RE:RE:RE:RE:Updates!?I think you have some very fair comments about communication. I would make the following observation on your 10:1 ratio, MedX versus Empower. It is true that Empower releases news it seems every other day about their progress. This costs the company and shareholders a lot of money.In february of 2021 Empower stock was at $2.26 cents. They have released news constantly and the share price is $.37 today. That is quite a decrease given their news and POTENTIAL.Why? It wasn't that they didn't communicate it just takes longer than investors are willing to wait for the revenue results.
In the current market the mid-large cap shares have done well and by any measure are deeply overvalued. This is mainly because the system is awash with cash and there was no money in to be made interest bearing instruments. Other shares benefited from sector buying;Bitcoin,EV's,cannabis etc's.
So at the end of the day microcap shares are followed by mostly retail investors who have low risk tolerance and chase stories. Not all but a fair amount of them. Therefore, th eshares can be quite volatile. However, if one is patient and buys when tax-loss selling or a seller just steps into the market and dumps their shares a lot of money can be made on price volatility.
I think MedX indicated they had a number of pilots in the near future and depending on their success and turning these pilots into large scale rollouts MedX will have its day. I cannot imagine that they could land a CFO as talented as Lesley Bourget seems to be without her doing her due diligence and deciding this was the real deal.
I can say with great conviction at $,09 cents from a recent high of $.22 cents all they have done was hire a lot of great talent, got rid of people who were not impactive, landed Italy, Empower is now installed and operational, launched the beta version of their HD camera. So all of these actions should leed to greater revenue. If they start announcing additional pilots this share price will look pretty cheap.